Search Filters

Search Results

Found 1 results

510(k) Data Aggregation

    K Number
    K200820

    Validate with FDA (Live)

    Manufacturer
    Date Cleared
    2020-11-13

    (228 days)

    Product Code
    Regulation Number
    876.5130
    Reference & Predicate Devices
    Predicate For
    N/A
    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    SpeediCath Compact Set is indicated for use by patients with chronic urine retention and patients with a post void residual volume (PVR) due to neurogenic and non-neurogenic voiding dysfunction. The catheter is inserted into the urethra to reach the bladder allowing urine to drain. This device is intended for males only.

    Device Description

    The SpeediCath Compact Set is a sterile, ready to use intermittent catheter for males. It is a single use catheter with an integrated urine bag. The catheter is a hollow tube consisting of polyurethane and methylmethacrylate-acrylonitrilebutadiene-styrene polymer [MABS]. It facilitates drainage of urine from the bladder through the urethra to the collection bag. It is available in one size FR/CH 12/18. The catheter is hydrophilic coated and placed in a sterile solution (swelling medium) containing polyethylene glycol (PEG) inside a tube. The swelling medium resides between the catheter and the tube and lubricates the catheter.

    AI/ML Overview

    The provided text describes the 510(k) premarket notification for the "SpeediCath Compact Set" Urological Catheter and Accessories, product number K200820, from Coloplast A/S. This document focuses on demonstrating substantial equivalence to a predicate device (SpeediCath Compact Set, K121458), rather than detailing specific acceptance criteria and a study to prove a device meets those criteria from an AI/algorithm perspective.

    The document does not describe an AI/algorithm-based device and therefore does not contain information on:

    • Acceptance criteria for an AI algorithm's performance.
    • A study proving an AI device meets acceptance criteria.
    • Sample size used for an AI test set or its data provenance.
    • Number or qualifications of experts for ground truth.
    • Adjudication methods for an AI test set.
    • Multi-Reader Multi-Case (MRMC) comparative effectiveness studies.
    • Standalone performance of an AI algorithm.
    • Type of ground truth used for AI models.
    • Sample size for an AI training set.
    • How ground truth for an AI training set was established.

    Instead, the document focuses on the substantial equivalence of a physical medical device (a urological catheter) based on non-clinical performance testing.

    Here's a summary of the non-clinical performance testing for the SpeediCath Compact Set, as described in the document:

    1. Table of Acceptance Criteria and Reported Device Performance:

    The document does not present a table of specific numerical acceptance criteria (e.g., a specific coefficient of friction value) and reported performance against those. Instead, it indicates that testing was conducted per applicable standards and that "the results were acceptable."

    Test CategoryStandard/MethodReported Performance
    BiocompatibilityISO 10993-1:2018; FDA Guidance "Use of International Standard ISO 10993-1" (2016)Acceptable
    Cytotoxicity(Included in Biocompatibility)Acceptable
    Irritation(Included in Biocompatibility)Acceptable
    Sensitivity(Included in Biocompatibility)Acceptable
    Chemical Characterization(Included in Biocompatibility)Acceptable
    Coefficient of FrictionASTM D1894:2014Acceptable
    CorrosionEN ISO 20696:2018; EN 1616:1997Acceptable
    Shelf LifeASTM F1980-16 (Accelerated and Real-Time aged)Acceptable
    Sterilization Dose SettingISO 11137-1:2015; ISO/TS 13004:2013Acceptable
    Impact of Swelling Medium Modification:
    Catheter coating - finger testEstablished methodsAcceptable
    Catheter coating dry out in airEstablished methodsAcceptable
    Catheters, objective friction measurementEstablished methodsAcceptable
    pH of the swelling mediumEstablished methodsAcceptable
    Osmolality of the swelling mediumEstablished methodsAcceptable

    2. Sample size used for the test set and the data provenance:

    • Sample Size: Not specified in the provided text for any of the tests.
    • Data Provenance: The document does not specify the country of origin of the data or whether the studies were retrospective or prospective.

    3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts:

    • This information is not applicable and not provided. The tests described are non-clinical, laboratory-based performance tests, not clinical evaluations requiring expert interpretation of ground truth in the context of an AI device.

    4. Adjudication method for the test set:

    • This information is not applicable and not provided, as the tests are non-clinical.

    5. If a multi-reader multi-case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance:

    • Not applicable, as this is not an AI device.

    6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done:

    • Not applicable, as this is not an AI device.

    7. The type of ground truth used:

    • Not applicable, as the tests are non-clinical hardware performance evaluations against established physical/chemical standards, not against "ground truth" as it would be defined for an AI diagnostic or predictive model (e.g., pathology, outcomes data, expert consensus). The "ground truth" here is effectively the established engineering and biological standards.

    8. The sample size for the training set:

    • Not applicable, as this is not an AI device.

    9. How the ground truth for the training set was established:

    • Not applicable, as this is not an AI device.

    Conclusion from document: The document concludes that "The performance testing demonstrates the subject device is as safe and as effective as the predicate device." This is the basis for the FDA's substantial equivalence determination for this physical medical device.

    Ask a Question

    Ask a specific question about this device

    Page 1 of 1